1,225 research outputs found
Deeply-Supervised CNN for Prostate Segmentation
Prostate segmentation from Magnetic Resonance (MR) images plays an important
role in image guided interven- tion. However, the lack of clear boundary
specifically at the apex and base, and huge variation of shape and texture
between the images from different patients make the task very challenging. To
overcome these problems, in this paper, we propose a deeply supervised
convolutional neural network (CNN) utilizing the convolutional information to
accurately segment the prostate from MR images. The proposed model can
effectively detect the prostate region with additional deeply supervised layers
compared with other approaches. Since some information will be abandoned after
convolution, it is necessary to pass the features extracted from early stages
to later stages. The experimental results show that significant segmentation
accuracy improvement has been achieved by our proposed method compared to other
reported approaches.Comment: Due to a crucial sign error in equation
Recommended from our members
PI-RADS v2 - What you need to know
Prostate cancer is the second most prevalent cancer in men worldwide and its incidence is expected to double by 2030. Multi-parametric magnetic resonance imaging (MRI) incorporating anatomical and functional imaging has now been validated as a means of detecting and characterising prostate tumours and can aid in risk stratification and treatment selection. The European Society of Urogenital Radiology (ESUR) in 2012 established the Prostate Imaging-Reporting and Data System (PI-RADS) guidelines aimed at standardising the acquisition, interpretation and reporting of prostate MRI. Subsequent experience and technical developments have highlighted some limitations, and a joint steering committee formed by the American College of Radiology, ESUR, and the AdMeTech Foundation have recently announced an updated version of the proposals. We summarise the main proposals of PI-RADS version 2, explore the evidence behind the recommendations, and highlight key differences for the benefit of those already familiar with the original.TB is supported the National Institute for Health Research (NIHR) Cambridge Biomedical Research Centre.This is the author accepted manuscript. The final version is available from Elsevier via http://dx.doi.org/10.1016/j.crad.2015.06.09
DeepOrgan: Multi-level Deep Convolutional Networks for Automated Pancreas Segmentation
Automatic organ segmentation is an important yet challenging problem for
medical image analysis. The pancreas is an abdominal organ with very high
anatomical variability. This inhibits previous segmentation methods from
achieving high accuracies, especially compared to other organs such as the
liver, heart or kidneys. In this paper, we present a probabilistic bottom-up
approach for pancreas segmentation in abdominal computed tomography (CT) scans,
using multi-level deep convolutional networks (ConvNets). We propose and
evaluate several variations of deep ConvNets in the context of hierarchical,
coarse-to-fine classification on image patches and regions, i.e. superpixels.
We first present a dense labeling of local image patches via
and nearest neighbor fusion. Then we describe a regional
ConvNet () that samples a set of bounding boxes around
each image superpixel at different scales of contexts in a "zoom-out" fashion.
Our ConvNets learn to assign class probabilities for each superpixel region of
being pancreas. Last, we study a stacked leveraging
the joint space of CT intensities and the dense
probability maps. Both 3D Gaussian smoothing and 2D conditional random fields
are exploited as structured predictions for post-processing. We evaluate on CT
images of 82 patients in 4-fold cross-validation. We achieve a Dice Similarity
Coefficient of 83.66.3% in training and 71.810.7% in testing.Comment: To be presented at MICCAI 2015 - 18th International Conference on
Medical Computing and Computer Assisted Interventions, Munich, German
Update on the ICUD-SIU consultation on multi-parametric magnetic resonance imaging in localised prostate cancer
Introduction: Prostate cancer (PCa) imaging is a rapidly evolving field. Dramatic improvements in prostate MRI during the last decade will probably change the accuracy of diagnosis. This chapter reviews recent current evidence about MRI diagnostic performance and impact on PCa management. Materials and methods: The International Consultation on Urological Diseases nominated a committee to review the literature on prostate MRI. A search of the PubMed database was conducted to identify articles focussed on MP-MRI detection and staging protocols, reporting and scoring systems, the role of MP-MRI in diagnosing PCa prior to biopsy, in active surveillance, in focal therapy and in detecting local recurrence after treatment. Results: Differences in opinion were reported in the use of the strength of magnets [1.5 Tesla (T) vs. 3T] and coils. More agreement was found regarding the choice of pulse sequences; diffusion-weighted MRI (DW-MRI), dynamic contrast-enhanced MRI (DCE MRI), and/or MR spectroscopy imaging (MRSI) are recommended in addition to conventional T2-weighted anatomical sequences. In 2015, the Prostate Imaging Reporting and Data System (PI-RADS version 2) was described to standardize image acquisition and interpretation. MP-MRI improves detection of clinically significant PCa (csPCa) in the repeat biopsy setting or before the confirmatory biopsy in patients considering active surveillance. It is useful to guide focal treatment and to detect local recurrences after treatment. Its role in biopsy-naive patients or during the course of active surveillance remains debated. Conclusion: MP-MRI is increasingly used to improve detection of csPCa and for the selection of a suitable therapeutic approach
- …